Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 14, 2018
Nanologica AB has entered into a service agreement with global CDMO Sterling Pharma Solutions for the large-scale production of silica particles.
read more
Wednesday, March 14, 2018
Crown Bioscience has been selected by Phanes Therapeutics as a strategic partner to advance their oncology drug discovery pipeline.
read more
Wednesday, March 14, 2018
Minakem has initiated the extension of its manufacturing capacity at its Dunkirk site in France.
read more
SanBio Group and Hitachi Chemical jointly announced that they will manufacture SB623, a proprietary regenerative medicine product under development by SanBio.
read more
PAREXEL announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea.
read more
Waverley Pharma announced its wholly-owned Irish Subsidiary has submitted a Marketing Authorization application through the European Union's De-Centralized Procedure for an anti-cancer generic drug.
read more
Intec Pharma has partnered with LTS for the manufacture of the Accordion Pill Carbidopa/Levodopa as a treatment for Parkinson's Disease symptoms.
read more
Pace Analytical announces the acquisition of REIC Laboratories, a full-service environmental testing laboratory with multiple locations throughout Virginia and West Virginia.
read more
Citoxlab Group has entered into a definitive agreement to acquire Solvo Biotechnology, a CRO specializing in drug transporter studies and the assessment of Drug-Drug Interactions.
read more
Boehringer Ingelheim and Eli Lilly announced plans to expand their clinical trial program for empagliflozin in chronic heart failure with the EMPERIAL clinical trials.
read more
Lannett has entered into separate agreements with three strategic alliance partners.
read more
BioDuro announced the acquisition of Molecular Response and its translational oncology research platform, including its biobank of more than 100,000 viable tumor specimens.
read more
Skyland Analytics announced the appointment of James C. Mullen to Skyland's Advisory Board.
read more
Virginia Governor Ralph Northam announced that Panaceutics will invest $5.8 million to establish a research and development and high-tech manufacturing facility.
read more
Theradex Oncology has announced the release of their proprietary CTMS that provides real-time access to analytics allowing for maximum study visibility for enhanced informed decisions.
read more